BioVaxys Technology Corp. Share Price OTC Markets
Equities
BVAXF
CA09076M1014
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0357 USD | -31.21% | -32.00% | -12.93% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 37L 31Cr |
---|---|---|---|---|---|
Net income 2022 | -1.1Cr -92Cr | Net income 2023 | -70L -58Cr | EV / Sales 2022 | - |
Net cash position 2022 | 1L 1.19Cr | Net cash position 2023 | 977 81.6T | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.72
x | P/E ratio 2023 |
-0.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.68% |
1 day | -31.21% | ||
1 week | -32.00% | ||
Current month | -28.46% | ||
1 month | -29.31% | ||
3 months | -39.08% | ||
6 months | +2.00% | ||
Current year | -12.93% |
Managers | Title | Age | Since |
---|---|---|---|
James Passin
FOU | Founder | 52 | - |
Kenneth Kovan
FOU | Founder | - | - |
David Berd
FOU | Founder | 79 | 30/20/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Passin
FOU | Founder | 52 | - |
Anthony Dutton
BRD | Director/Board Member | 66 | 29/22/29 |
Craig Loverock
BRD | Director/Board Member | 54 | 08/22/08 |
Date | Price | Change | Volume |
---|---|---|---|
16/24/16 | 0.0357 | -31.21% | 60 008 |
15/24/15 | 0.0519 | -0.19% | 60,340 |
12/24/12 | 0.052 | 0.00% | 133,300 |
11/24/11 | 0.052 | -4.59% | 58,674 |
10/24/10 | 0.0545 | +3.81% | 500 |
Delayed Quote OTC Markets, July 16, 2024 at 09:41 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+20.50% | 13TCr | |
+24.51% | 12TCr | |
+25.44% | 2.77TCr | |
-18.73% | 2.03TCr | |
-15.17% | 1.68TCr | |
-16.34% | 1.56TCr | |
+13.02% | 1.48TCr | |
-47.10% | 1.46TCr | |
+56.82% | 1.44TCr |
- Stock Market
- Equities
- BIOV Stock
- BVAXF Stock